Nitrofurantoin (Nitrofurantoin PHARMC)
Nitrofurantoin
Pharmacorp (Pty) Ltd
Registration
- Applicant
- Pharmacorp (Pty) Ltd
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Nitrofurantoin 50 PHARMC EACH CAPSULE CONTAINS NITROFURANTOIN 50,0 mg | 50 | 55086255/18.5/0862 | Registered | Not determined | None |
| Nitrofurantoin 100 PHARMC EACH CAPSULE CONTAINS NITROFURANTOIN 100,0 mg | 100 | 550863 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Nitrofurantoin
- except preparations thereof intended for application to the skin.
Consolidated Schedules 06 July 2026, line 7287
S1: Nitrofurantoin
- when intended for application to the skin.
Consolidated Schedules 06 July 2026, line 919
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1-[(E)-(5-Nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
Drag to rotate. Structure from PubChem CID 6604200.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.